Cargando…

Two-Year Changes in Hyperuricemia and Risk of Diabetes: A Five-Year Prospective Cohort Study

BACKGROUND: Hyperuricemia is known to be a risk factor for diabetes. However, information is limited regarding the association between changes in hyperuricemia and the risk of diabetes. METHODS: A total of 15,403 participants who were free of diabetes at the time of 2009 and 2011 surveys in the Beij...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jia, Tao, Lixin, Zhao, Zhan, Mu, Yongmin, Zou, Dechun, Zhang, Jingbo, Guo, Xiuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332976/
https://www.ncbi.nlm.nih.gov/pubmed/30693289
http://dx.doi.org/10.1155/2018/6905720
_version_ 1783387474232344576
author Liu, Jia
Tao, Lixin
Zhao, Zhan
Mu, Yongmin
Zou, Dechun
Zhang, Jingbo
Guo, Xiuhua
author_facet Liu, Jia
Tao, Lixin
Zhao, Zhan
Mu, Yongmin
Zou, Dechun
Zhang, Jingbo
Guo, Xiuhua
author_sort Liu, Jia
collection PubMed
description BACKGROUND: Hyperuricemia is known to be a risk factor for diabetes. However, information is limited regarding the association between changes in hyperuricemia and the risk of diabetes. METHODS: A total of 15,403 participants who were free of diabetes at the time of 2009 and 2011 surveys in the Beijing Health Management Cohort (BHMC) study were recruited and followed up until 2016. Participants were classified into four groups according to 2-year changes in hyperuricemia: no hyperuricemia, remittent hyperuricemia, incident hyperuricemia, and persistent hyperuricemia. Modified Poisson regression models were used to evaluate the effect of 2-year changes in hyperuricemia on the risk of diabetes. RESULTS: During the 5-year follow-up, we identified 841 new cases of diabetes (216 women). Remittent hyperuricemia and incident hyperuricemia had a 35% and 48% higher risk for developing diabetes compared with no hyperuricemia. Especially, persistent hyperuricemia was associated with a 75% higher risk of diabetes (RR = 1.75, 95% CI = 1.47-2.08). Compared with minor serum uric acid (SUA) change, over 10% decline and over 30% increase in SUA levels were subsequently associated with lower (RR = 0.84, 95% CI = 0.72-0.99) and higher (RR = 1.71, 95% CI = 1.27-2.30) diabetes risk, respectively. CONCLUSIONS: Changes in hyperuricemia, especially persistent hyperuricemia, are more appropriate to reflect the risk of diabetes than a single measurement of hyperuricemia at baseline. Strategies aiming at preventing hyperuricemia are urgently needed to reduce the increasing burden of diabetes.
format Online
Article
Text
id pubmed-6332976
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-63329762019-01-28 Two-Year Changes in Hyperuricemia and Risk of Diabetes: A Five-Year Prospective Cohort Study Liu, Jia Tao, Lixin Zhao, Zhan Mu, Yongmin Zou, Dechun Zhang, Jingbo Guo, Xiuhua J Diabetes Res Research Article BACKGROUND: Hyperuricemia is known to be a risk factor for diabetes. However, information is limited regarding the association between changes in hyperuricemia and the risk of diabetes. METHODS: A total of 15,403 participants who were free of diabetes at the time of 2009 and 2011 surveys in the Beijing Health Management Cohort (BHMC) study were recruited and followed up until 2016. Participants were classified into four groups according to 2-year changes in hyperuricemia: no hyperuricemia, remittent hyperuricemia, incident hyperuricemia, and persistent hyperuricemia. Modified Poisson regression models were used to evaluate the effect of 2-year changes in hyperuricemia on the risk of diabetes. RESULTS: During the 5-year follow-up, we identified 841 new cases of diabetes (216 women). Remittent hyperuricemia and incident hyperuricemia had a 35% and 48% higher risk for developing diabetes compared with no hyperuricemia. Especially, persistent hyperuricemia was associated with a 75% higher risk of diabetes (RR = 1.75, 95% CI = 1.47-2.08). Compared with minor serum uric acid (SUA) change, over 10% decline and over 30% increase in SUA levels were subsequently associated with lower (RR = 0.84, 95% CI = 0.72-0.99) and higher (RR = 1.71, 95% CI = 1.27-2.30) diabetes risk, respectively. CONCLUSIONS: Changes in hyperuricemia, especially persistent hyperuricemia, are more appropriate to reflect the risk of diabetes than a single measurement of hyperuricemia at baseline. Strategies aiming at preventing hyperuricemia are urgently needed to reduce the increasing burden of diabetes. Hindawi 2018-12-30 /pmc/articles/PMC6332976/ /pubmed/30693289 http://dx.doi.org/10.1155/2018/6905720 Text en Copyright © 2018 Jia Liu et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Liu, Jia
Tao, Lixin
Zhao, Zhan
Mu, Yongmin
Zou, Dechun
Zhang, Jingbo
Guo, Xiuhua
Two-Year Changes in Hyperuricemia and Risk of Diabetes: A Five-Year Prospective Cohort Study
title Two-Year Changes in Hyperuricemia and Risk of Diabetes: A Five-Year Prospective Cohort Study
title_full Two-Year Changes in Hyperuricemia and Risk of Diabetes: A Five-Year Prospective Cohort Study
title_fullStr Two-Year Changes in Hyperuricemia and Risk of Diabetes: A Five-Year Prospective Cohort Study
title_full_unstemmed Two-Year Changes in Hyperuricemia and Risk of Diabetes: A Five-Year Prospective Cohort Study
title_short Two-Year Changes in Hyperuricemia and Risk of Diabetes: A Five-Year Prospective Cohort Study
title_sort two-year changes in hyperuricemia and risk of diabetes: a five-year prospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332976/
https://www.ncbi.nlm.nih.gov/pubmed/30693289
http://dx.doi.org/10.1155/2018/6905720
work_keys_str_mv AT liujia twoyearchangesinhyperuricemiaandriskofdiabetesafiveyearprospectivecohortstudy
AT taolixin twoyearchangesinhyperuricemiaandriskofdiabetesafiveyearprospectivecohortstudy
AT zhaozhan twoyearchangesinhyperuricemiaandriskofdiabetesafiveyearprospectivecohortstudy
AT muyongmin twoyearchangesinhyperuricemiaandriskofdiabetesafiveyearprospectivecohortstudy
AT zoudechun twoyearchangesinhyperuricemiaandriskofdiabetesafiveyearprospectivecohortstudy
AT zhangjingbo twoyearchangesinhyperuricemiaandriskofdiabetesafiveyearprospectivecohortstudy
AT guoxiuhua twoyearchangesinhyperuricemiaandriskofdiabetesafiveyearprospectivecohortstudy